Developing an Optimal Biofunctional Scaffold for Hematopoietic Stem Cell Quiescent Maintenance and Expansion
Keywords:
Quiescence, Stemness, Hydrogel, Scaffold, Stemregenin 1, Blood, Differentiate, Proliferate, Stem cells.Abstract
Hematopoietic stem cells (HSCs), characterized by their CD34 glycoprotein expression, can be extensively exploited in a variety of clinical applications to treat bone-marrow related disorders and cancers, which affect hundreds of thousands worldwide. HSCs are known to efficiently self-renew and maintain their quiescent state in their in vivo microenvironment, but rapidly lose their multipotency in vitro due to quick onsets of differentiation. Shortages of available donor cells have led to scientific interest in developing biofunctional scaffolds – such as cross-linked polymer hydrogels – that mimic the natural stem cell niche. Here we show that a firm, gelatin-based hydrogel cross-linked by microbial transglutaminase (mTG) (in a ratio of 1:25 mTG to gelatin) is ideal for quiescent self-renewal, and that the purine derivative, Stemregenin 1 (SR1), aids in directing cell migration, proliferation, and stemness. The 1:25 ratio with exposure to SR1 yielded a promisingly high stemness level of 94.53%. Our results demonstrate the previously undocumented effectiveness of gelatin hydrogels as biomimetic scaffolds suitable for HSC expansion. Furthermore, our findings and the culture system we have developed are expected to facilitate bone marrow disease treatment by providing large quantities of quiescent HSCs for medical applications and potentially diminishing the high demand for marrow donors.
References
http://www.ij.org/bone-marrow-statistics
2. Gunsilius, E., Gastl, G., & Petzer, A. (2001). Hematopoietic stem cells.
Biomedicine & Pharmacotherapy, 55, 186-194.
3. 5. Hematopoietic Stem Cells [Stem Cell Information]. (2011, January
1). Retrieved September 17, 2014.
4. Pietras, E., Warr, M., & Passegue, E. (2011). Cell cycle regulation in
hematopoietic stem cells. Journal of Experimental Medicine, 195,
709-720.
5. Raic, A., Rödling, L., Kalbacher, H., & Lee-Thedieck, C. (2014).
Biomimetic macroporous PEG hydrogels as 3D scaffolds for the
multiplication of human hematopoietic stem and progenitor cells.
Biomaterials, (35), 929-940.
6. Leisten, I., Kramann, R., Ferreira, et al. (2011). 3D co-culture of
hematopoietic stem and progenitor cells and mesenchymal stem
cells in collagen scaffolds as a model of the hematopoietic niche.
Biomaterials, 33, 1736-1747.
7. Muth, C., Steinl, C., Klein, G., Lee-Thedieck, C., & Tjwa, M. (2013).
Regulation of Hematopoietic Stem Cell Behavior by the
Nanostructured Presentation of Extracellular Matrix Components.
PLoS ONE, 8, E54778-E54778.
8. Lutolf, M., Doyonnas, R., Havenstrite, K., Koleckar, K., & Blau, H.
(2008). Perturbation of single hematopoietic stem cell fates in
artificial niches. Integrative Biology, 1, 59-69.
9. Wilson, A., & Trumpp, A. (2006). Bone-marrow Haematopoietic-stem-
cell Niches. Nature Reviews Immunology, 6, 93-106.
10. Krause, D. (2002). Regulation of hematopoietic stem cell fate.
Oncogene, 21, 3262-3269.
11. Zandstra, P. (1997). Cytokine manipulation of primitive human
hematopoietic cell self-renewal. Proceedings of the National
Academy of Sciences, 94, 4698-4703.
12. Boitano, A., Wang, J., Romeo, R., et al. (2010). Aryl Hydrocarbon
Receptor Antagonists Promote the Expansion of Human
Hematopoietic Stem Cells. Science, 329, 1345-1348.
13. Zhu, J., & Marchant, R. (2011). Design Properties Of Hydrogel
Tissue-engineering Scaffolds.Expert Review of Medical Devices, 8,
607-626.
14. Sharma, M., Limaye, L., & Kale, V. (2012). Mimicking the functional
hematopoietic stem cell niche in vitro: Recapitulation of marrow
physiology by hydrogel-based three-dimensional cultures of
mesenchymal stromal cells. Haematologica, 97, 651-660.
15. Henschler, R., Brugger, W., Luft, T., Frey, T., & Kanz, L. (1994).
Maintenance of transplantation potential in ex vivo expanded
CD34(+)-selected human peripheral blood progenitor cells. Blood,
84, 2898-2903.
16. Grigoryev, Y. (2013, July 3). Cell Counting with a Hemocytometer:
Easy as 1, 2, 3. Retrieved September 17, 2014.
17. Gobin, A. (2003). Cell Migration Through Biomimetic Hydrogel
Scaffolds (pp. 1-120). Houston, TX: ProQuest Information and
Learning Company.
18. Miyajima, A., Ito, Y., & Kinoshita, T. (1999). Cytokine signaling for
proliferation, survival, and death in hematopoietic cells.
International Journal of Hematology, 69, 137-146.
19. Guilak, F., Cohen, D., Estes, B., Gimble, J., Liedtke, W., & Chen, C.
(2009). Control of Stem Cell Fate by Physical Interactions with the
Extracellular Matrix. Cell Stem Cell, 5, 17-26.
20. Guo, W., Frey, M., Burnham, N., & Wang, Y. (2006). Substrate
Rigidity Regulates the Formation and Maintenance of Tissues.
Biophysical Journal, 90, 2213-2220.
21. Mammoto, T., Mammoto, A., Torisawa, Y., et al. (2011).
Mechanochemical Control of Mesenchymal Condensation and
Embryonic Tooth Organ Formation. Developmental Cell, 21, 758-
769.
22. Emerman, J., Burwen, S., & Pitelka, D. (1979). Substrate properties
influencing ultrastructural differentiation of mammary epithelial
cells in culture. Tissue and Cell, 11, 109-119.
23. Hadjipanayi, E., Mudera, V., & Brown, R. (2009). Close dependence
of fibroblast proliferation on collagen scaffold matrix stiffness.
Journal of Tissue Engineering and Regenerative Medicine, 3, 77-84.
24. Mcdermott, M., Chen, T., Williams, C., Markley, K., & Payne, G.
(2004). Mechanical Properties of Biomimetic Tissue Adhesive Based
on the Microbial Transglutaminase-Catalyzed Crosslinking of
Gelatin. Biomacromolecules, 5, 1270-1279.
25. Chen, P., Yang, K., Wu, C., Yu, J., Lin, F., & Sun, J. (2014).
Fabrication of large perfusable macroporous cell-laden hydrogel
scaffolds using microbial transglutaminase. Acta Biomaterialia, 10,
912-920.
26. Yung, C., Wu, L., Tullman, J., Payne, G., Bentley, W., & Barbari, T.
(2008). Transglutaminase crosslinked gelatin as a tissue
engineering scaffold. Journal of Biomedical Materials Research Part
A, 83, 1039-1046.
